Transcranial magnetic stimulation as a provocation for epileptic seizures in multiple sclerosis

Multiple Sclerosis

Volumn 10, Issue 4, 2004, Pages 475-476

  Haupts, Michael R ^a   Daum, S ^a   Ahle, G ^a   Holinka, B ^a   Gehlen, W ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Corticosubcortical lesions; Epilepsy; MRI; Multiple sclerosis; Safety; Transcranial magnetic stimulation (TMS)

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; GLATIRAMER; INTERFERON; LAMOTRIGINE; OLANZAPINE; THYROXINE; VALPROIC ACID; VITAMIN;

ACUTE DISEASE; ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CONTRAST ENHANCEMENT; DIAGNOSTIC PROCEDURE; ELECTROENCEPHALOGRAPHY; EPILEPTIC DISCHARGE; EPILEPTOGENESIS; FEMALE; FOCAL EPILEPSY; GRAND MAL EPILEPSY; GRAND MAL SEIZURE; HUMAN; MOTOR CORTEX; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESIS; PSYCHOSIS; RIGHT HEMISPHERE; SEIZURE; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 4344599077     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458504ms1062cr     Document Type: Article

References (14)

1. Sokic DV, Stojsavljevic N, Drulovic J, Dujmovic I, Mesaros S, Ercegovac M et al. Seizures in multiple sclerosis. Epilepsia 2001; 42: 72-79.
2. Eriksson M, Ben-Menachem E, Andersen O. Epileptic seizures, cranial neuralgias and paroxysmal symptoms in remitting and progressive multiple sclerosis. Mult Scler 2002; 8: 495-99.
3. Striano P, Striano S, Carrieri PB, Boccella P. Epilepsia partialis continua as a first symptom of multiple sclerosis: electrophysiological study of one case. Mult Scler 2003; 9: 199-203.
4. Truyen L, Barkhof F, Frequin ST, Polman CH, Tobi H, Hammes OR et al. Magnetic resonance imaging of epilepsy in multiple sclerosis: a case control study. Implications for treatment trials with 4-aminopyridine. Mult Scler 1996; 1: 213-17.
5. Thompson AJ, Kermode AG, Moseley IF, MacManus DG, McDonald WI. Seizures due to multiple sclerosis: seven patients with MRI correlations. J Neurol Neurosurg Psychiatry 1993; 56: 1317-20.
6. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain 1999; 122: 17-26.
7. Polman CH, Bertelsmann FW, van Loenen AC, Koetsier JC. 4-Aminopyridine in the treatment of patients with multiple sclerosis. Long-term efficacy and safety. Arch Neurol 1994; 51: 292-96.
8. Spatt J, Chaix R, Mamoli B. Epileptic and non-epileptic seizures in multiple sclerosis. J Neurol 2001; 248: 2-9.
9. Kandler R. Safety of transcranial magnetic stimulation. Lancet 1990; 335: 469-70.
10. Schulze-Bonhage A, Scheufler K, Zentner J, Elger CE. Safety of single and repetitive focal transcranial magnetic stimuli as assessed by intracranial EEG recordings in patients with partial epilepsy. J Neurol 1999; 246: 914-19.
11. Hömberg V, Netz J. Generalised seizures induced by transcranial magnetic stimulation of motor cortex. Lancet 1989; 334: 1223.
12. Classen J, Witte O, Schlaug G, Seitz R, Holthausen H, Benecke R. Epileptic seizures triggered directly by focal transcranial magnetic stimulation. Electroenceph Clin Neurophysiol 1995; 24: 19-25.
13. Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol 1998; 108: 1-16.
14. Chen R, Classen J, Gerloff C, Celnik P, Wassermann EM, Hallett M et al. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 1997; 48: 1398-403.